FHI Logo
    Search fhi.org
pixel
  Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
pixel pixel

Orphans.fhi.org Contribute Now Orphans.fhi.org
Bookmark and Share

Email this to a friend

Research

Contraceptive and Reproductive Health Technologies and Research Utilization Program

The Contraceptive and Reproductive Health Technologies Research and Utilization (CRTU) program is a five-year, USAID-sponsored assistance agreement (2005-2010) with Family Health International. Through the CRTU program, FHI works with USAID, its missions, and other partners to expand the range and support the use and availability of safe, effective, acceptable, and affordable technologies that prevent unplanned pregnancy and sexually transmitted infections, including HIV.

Research for impact

FHI's work affects public health on a local, regional, and global level. In collaboration with our partners, we focus on high priority research and programs and strive to improve reproductive health policy and practice by generating evidence that affects international standards and host country norms and guidelines for the provision of services.

 

Under the CRTU, Family Health International focuses on the following activities:

 

  • Ensuring that new and improved contraceptive and reproductive health technologies are developed, evaluated, and approved--FHI is a recognized leader in the design, implementation, and analysis of research on contraceptive safety, efficacy, and acceptability. Under the CRTU, we are conducting clinical trials on new contraceptive methods and evaluating improvements in methods that are already available. Areas of focus include increasing long-term and permanent contraceptive options for women and men, evaluating improvements in hormonal method use, and addressing issues related to contraception and HIV.
  • Ensuring development, evaluation, and regulatory approval for microbicides and microbicidal spermicides--FHI is working to complete ongoing microbicide studies, identify and train staff at new study sites, evaluate innovative microbicide delivery systems, conduct contraceptive efficacy trials of candidate microbicides, and ensure the quality of new microbicides and production facilities.
  • Promoting use of contraceptives, microbicides, and other reproductive health technologies in the developing world--Under the CRTU, FHI is conducting behavioral and health services research and related research utilization activities that advance evidence-based services in targeted countries. We are examining factors that reduce access to services and designing interventions to increase the provision of family planning (including integration of contraception into HIV programs), reduce barriers to service provision, and identify effective strategies to increase the quality of information and counseling available to clients.

Focus countries

Under the CRTU, FHI is concentrating its efforts in a few targeted countries in order to achieve the greatest impact with available resources.  FHI and its partners have a strong presence in the focus countries.  As a result, we enjoy good working relationships with local stakeholders and policy-makers, who inform our research and work with us to ensure that emerging results are put into practice.  Our presence in these countries also helps us integrate results into service programs and more widely apply key results through partners' service delivery networks.

 

Our partners

We are working in collaboration with a wide range of USAID cooperating agencies, international normative bodies, faith-based organizations, country-based programs, and service providers. Collaborating partners include the INFO Project at Johns Hopkins University Center for Communication Programs; the ACQUIRE Project (EngenderHealth); CONRAD; Management Sciences for Health Inc.; PATH; the Population Council; and Save the Children. Other partners will be added as the project unfolds.